Is GERN Worth Buying in 2026?

Geron Corp

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-07

Here’s whether Geron Corp (GERN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-4.42% over 10 days); weak 1-year return of -25.0%; 3-month momentum negative (-27.8%). Currently 41.8% off its 52-week high. Score: -6/7.

Ready to act on this? 📈 Trade on Webull

GERN is trading below its 200-day MA ($1.40) — a key warning sign the longer-term trend is under pressure. An RSI of 32.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -25.0% compares to +24.4% for SPY (trailed the market by 49.4%). The current 41.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $7,500 today
vs. S&P 500 (SPY) — same period trailed market by 49.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.40)
Above 50-day MA ($1.47)
RSI(14) neutral zone (30–70) — currently 32.4
Positive return (-25.0%)
!Within 10% of period high (−41.8%)
Period Range $1.17
$1.04 $2.01
RSI (14) 32.4
0 · OversoldOverbought · 100

Key Metrics

Price$1.17
Period Return-25.0%
Period High$2.01
Period Low$1.04
Drawdown−41.8%
MA-50$1.47
MA-200$1.40
RSI (14)32.4
Avg Volume (30d)13.3M
vs. SPYtrailed by 49.4%
Return Rank#910 of 1245

Trade GERN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers